Apellis Pharmaceuticals, Inc.APLS
NYSE · Healthcare · Biotechnology · Mid-size company
$41.03+0.00 (+0.00%)
Price at 4:44 PM ET on Jul 17
After hours · opens in 17h 24mNext open: Friday, Nov 13, 9:30 AM ETOur call
We have not written a call on APLS yet.
+0.1% all timesince May 4, 2026
The news behind our call
What changed
From Scheduled market snapshot
Overview
In plain numbers
- Revenue grew 42% from a year earlier, to $1.1B in the last twelve months.
- It keeps 15 cents of every revenue dollar as operating profit, up from a loss of $8.06 in FY 2021.
- It turned 3.4% of revenue into free cash flow: $37.5M in the last twelve months.
- It owes $475.8M and holds $406.2M in cash and investments, so net debt is $69.6M.
Key figures
- Revenue (TTM)
- $1.1B
- Revenue growth, 1 year
- +42.5%
- Net income
- $133M
- EPS (diluted)
- $1.03
- Gross margin
- 64.3%
- Operating margin
- 14.9%
- Return on equity
- 46.0%
- Return on capital
- 37.8%
- Debt / equity
- 1.15
- Current ratio
- 3.63
- Buyback yield
- -5.48%
Key facts
- Company value
- $5.3B
- Price / last year's earnings
- 38.3×
- Past year's range
- 16.6141.14
- Yesterday's close
- $41.03
- Swings vs the market
- -0.3×smaller